The results of the trial into a new type of smart drug given to Acute Myeloid Leukaemia patients show that GO treatment could improve the effectiveness of chemotherapy without excessively increasing side effects, according to the study.
The study, published in the Journal of Clinical Oncology, said that this may provide a potential lifeline for older AML patients who are often too frail to tolerate more intensive chemotherapy regimes.
More top news
Ministers agree £7.8 billion bailout deal for recession-hit Greece after an 11-hour Brussels meeting.
There will be outbreaks of rain in central parts of the UK, while the rest of the country will remain dry.
A heartwarming photo of a five-month-old gorilla meeting a two-year-old girl is taking Facebook by storm.